Showing results (331-340 of 464) with videos related to

Sort By:
Pageof 47
Frontiers in Pharmacology|December 22, 2022
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-studyJaouad Azzahhafi, Thomas O Bergmeijer, Wout W A van den Broek, et al.
The Journal of Molecular Diagnostics : JMD|July 7, 2023
CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics KnowledgebaseVictoria M Pratt, Larisa H Cavallari, Makenzie L Fulmer, et al.
The Journal of Molecular Diagnostics : JMD|August 5, 2022
TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics KnowledgebaseVictoria M Pratt, Larisa H Cavallari, Makenzie L Fulmer, et al.
The Journal of Molecular Diagnostics : JMD|June 12, 2021
Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized TherapyVictoria M Pratt, Larisa H Cavallari, Andria L Del Tredici, et al.
Molecular Oncology|October 18, 2020
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNAManouk K Bos, Kazem Nasserinejad, Maurice P H M Jansen, et al.
European Journal of Human Genetics : EJHG|May 28, 2026
From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshopLoes Lindiwe Kreeftenberg, Lidewij Henneman, Tessel Rigter, et al.
Circulation|November 11, 2016
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart DiseaseVivan J M Baggen, Annemien E van den Bosch, Jannet A Eindhoven, et al.
The Journal of Urology|July 24, 2007
Tubular and interstitial nephrocalcinosisMaxime T M Kummeling, Bas W D de Jong, Charlie Laffeber, et al.
Therapeutic Drug Monitoring|July 22, 2008
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphismMadelon van Agteren, Victor W Armstrong, Ron H N van Schaik, et al.
The Pharmacogenomics Journal|September 9, 2015
Role of genetic variation in docetaxel-induced neutropenia and pharmacokineticsA J M Nieuweboer, M Smid, A-J M de Graan, et al.
Pageof 47